Literature DB >> 7062122

Favorable results with syringosubarachnoid shunts for treatment of syringomyelia.

C H Tator, K Meguro, D W Rowed.   

Abstract

From 1969 to 1979, 20 patients with syringomyelia were treated with a syringosubarachnoid shunt. The principal indications for this procedure were: significant progressive neurological deterioration and absent or minimal tonsillar ectopia. There were 15 patients with idiopathic syringomyelia, four with posttraumatic syringomyelia, and one with syringomyelia secondary to spinal arachnoiditis. The operations were performed with an operating microscope, and attention was directed to preserving thearachnoid membrane to ensure proper placement of the distal end of the shunt in an intact subarachnoid space. In all cases, a silicone rubber ventricular catheter was inserted into the syrinx through a posterior midline myelotomy. The average follow-up period was 5 years. A favorable result was obtained in 15 of the 20 patients (75%), including an excellent result with improvement of neurological deficit in 11 patients and a good result with cessation of progression in four patients. In the remaining five patients the result was poor with further progression of neurological deficit. A short duration of preoperative symptoms was usually a favorable prognostic feature. Four patients with a history of less than 6 months all had excellent results. Thirteen patients had a syringosubarachnoid shunt only, and all had good or excellent results. Seven patients had other surgical procedures, before, accompanying, or after shunt placement, and two had favorable results. Thus, the syringosubarachnoid shunt is an effective therapeutic modality for many patients with syringomyelia, particularly if there is little or no tonsillar herniation.

Entities:  

Mesh:

Year:  1982        PMID: 7062122     DOI: 10.3171/jns.1982.56.4.0517

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  23 in total

Review 1.  Pathogenesis of syringomyelia associated with Chiari type 1 malformation: review of evidences and proposal of a new hypothesis.

Authors:  Izumi Koyanagi; Kiyohiro Houkin
Journal:  Neurosurg Rev       Date:  2010-06-08       Impact factor: 3.042

2.  Syringo-subarachnoid shunt for syringomyelia associated with Chiari malformation (type 1).

Authors:  T Isu; Y Iwasaki; M Akino; H Abe
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 3.  The natural history and results of surgery in 50 cases of syringomyelia.

Authors:  C Mariani; M G Cislaghi; S Barbieri; F Filizzolo; F Di Palma; E Farina; G D'Aliberti; G Scarlato
Journal:  J Neurol       Date:  1991-12       Impact factor: 4.849

Review 4.  Hydromyelia: a critical review.

Authors:  J H Wisoff
Journal:  Childs Nerv Syst       Date:  1988-02       Impact factor: 1.475

5.  Direct syrinx drainage in patients with Chiari I malformation.

Authors:  Jehuda Soleman; Jonathan Roth; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2019-06-01       Impact factor: 1.475

6.  Syringosubarachnoid shunt for treatment of syringomyelia.

Authors:  J Vaquero; R Martínez; J Salazar; H Santos
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

Review 7.  Syringomyelia: a brief review of ontogenetic, experimental and clinical aspects.

Authors:  E Donauer; K Rascher
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

8.  Pathogenesis and treatment of delayed post-traumatic syringomyelia.

Authors:  R Van den Bergh
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

9.  Posttraumatic syringomyelia.

Authors:  P A La Haye; U Batzdorf
Journal:  West J Med       Date:  1988-06

10.  Delamination technique together with longitudinal incisions for treatment of Chiari I/syringomyelia complex: a prospective clinical study.

Authors:  Kadir Kotil; Tuğrul Ton; Rabia Tari; Yildiray Savas
Journal:  Cerebrospinal Fluid Res       Date:  2009-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.